exposures to breastfeeding women; impact on the infant
TRANSCRIPT
1
Exposures to Breastfeeding Women; Impact on the Infant
Beth Conover, MS, APRN, CGC
Director Nebraska Teratogen Information
Service/ NE MTB
Assistant Professor, UNMC
402-559-5071
Nebraska TIS
Service – Toll-free phone
consultation to patients or health care providers about exposures during pregnancy
Education – to public
and academic groups, including medical, nursing, genetic counseling, pharmacy and others
Research – collaborative
projects looking at outcomes of exposures to specific agents
2
Thomas Hale
Philip Anderson
https://www.ncbi.nlm.nih.gov/books/NBK501922/
Breastfeeding• Nursing is good for mother and
baby, but not if it results in harm to the baby via drugs in milk or avoidance of appropriate treatment for the mother.
• Most agents ingested by the mother will be excreted in the breast milk in some quantity. Fortunately, many are present in amounts less than 2% of the maternal dose. With some agents, however, even small amounts may present a risk to the infant.
3
Different Agents May Be Preferred
for Pregnancy vs Breastfeeding
Risk : Benefit Ratio• There is no one “right”
choice for every woman
• Healthy outcomes for mother and baby are the
rule rather than the
exception
• “No clinical decision is risk free.”
• Lee Cohen and
Zachary Stowe
• Always monitor the baby for
adverse effects!
Considerations
• Was agent used in
pregnancy?
• Age of infanto Medically fragile?
o Premature?
o Newborn
• 2/3 of adverse drug reactions occur
during the 1st month
• More than 3/4 occur during the first two
months
• Maternal dose/route
• Reason for use and
efficacy
• Acceptable alternatives
• Nursing or pumping?
• Totally breastfed? If
not, pattern of nursing
4
Basic Concepts: Amount of agent in milk
• Maternal serum levels
• Amount of the agent that is protein bound
• Lipid solubility
• pH
• Molecular size
• Half-life of medication
• Foremilk vs hindmilk
• Length of maternal therapy
• Timing of the dosage
• Bioavailability/amount absorbed through GI tract in both mother and baby
• Age of the infant
• Exposure to the agent in pregnancy as well as lactation
• Short term vs long term exposures
• Impact on milk production
Basic Concepts
• Estimated Infant
Dosageo Drug concentration in milk
x daily volume of milk
o Maximum dosage infant exposed to
• Milk Volumeo ~150mL/kg for exclusively
breastfed infant
o Colostrum only 13-17mL/kg
• M/P ratio
• Relative Infant
Dosageo (Infant dosage/maternal
dosage) x 100
o In one evaluation by the World Health Organization
Working Group, 47% had
RID less than 1% and 87%
had a RID less than 10%
Anderson, PO. Pharm Res (2018) 35: 45 https://doi.org/10.1007/s11095-017-2287-z
5
Issues in using RID or M/P ratio
to determine safety• Drugs have different
degrees of toxicity that
are difficult to quantify
• Pharmacogenetic
differences in mother
and infant
• Differences in bioavailability and liver
metabolism in the infant
• Does not take
infant’s age into
account
• Not all adverse drug reactions
related to doseo Allergic reactions
Anderson, PO. Pharm Res (2018) 35: 45 https://doi.org/10.1007/s11095-017-2287-z
Pharmacogenomics
Timing Nursing to Limit Infant Exposure
• Medications move in
and out of milk based
on maternal serum levels
• Strategy to limit amount
to baby:
o nurse first
o take medication
o defer nursing until past peak level (~2-4 hours for
short acting medications)
6
Minimizing Infant Exposures:
• Use short acting medications when possible
• Beware drugs with active metabolites
• Consider an alternative route of administration (topical, inhaled)
Minimizing Infant Exposures:
Choose drugs that pass poorly into milk
• Example: beta-blockers in breast milk o High risk--avoid while nursing neonates
• acebutolol, atenolol, nadolol, sotolol
o Moderate risk--avoid while nursing preterm neonates
• metoprolol, timolol
o Lower risk--alternatives with nursing neonates
• Labetalol, propranolol
Minimizing Infant Exposures:
• As a general rule, if the
medication can be safely given
directly to the infant, it is unlikely
to present a large risk via milk
• Exceptions include medications
that reduce breastmilk supply
• If there is concern that the infant
may be receiving clinically
important doses of a drug in milk,
measure the infant's plasma
drug concentration.
7
Drugs that may reduce milk supply:
o Ergotamine
o Bromocriptine
o Pseudoephedrine
o Estrogens
o Progestins (prior to
6-8 weeks postpartum)
AAP: Agents that are contraindicated
during breast-feeding
• Phenindione• Ergotamine• Drugs of abuse
(amphetamines, cocaine, heroin, marijuana, PCPlarge amts of nicotine)
• Cyclosporine
• Cytotoxic drugs (methotrexate)
• Lithium
• Radioactive compounds (I-131)
Approximate Duration for Interruption of
Breastfeeding After Drugs of Abuse
• Methamphetamine 24-36 hours
• Cocaine 24 hours
• Marijuana 24 hours
• Heroin 24 hours
• LSD 48 hours
• Phencyclidine 1-2 weeks
• Alcohol 1-2 hours per drink
8
Non-Medication Strategies
• The combination of bright
light therapy plus an
antidepressant significantly improves
nonseasonal major depressive disorder, and
light therapy alone is
more effective than antidepressant
monotherapy, a randomized, placebo-
controlled trial suggestso JAMA Psychiatry. 2016;73(1):56-63.
Hot Topics
9
Issues in Psychotherapeutic Drugs and
Breastfeeding• Baby may have withdrawal and other issues with
newborn adaptation due to exposure during
pregnancy.
• Reports of serious toxicities associated with some
antidepressants, anxiolytics, antipsychotics, & mood
stabilizers
• Infants metabolize and clear drugs at different rates from adults with individual babies varying widely
• Long term effects of psychotropics on
neurocognitive development are largely unknown
Psychiatric Medications in Lactation
• Anxiolytics (benzodiazepines)
o Sedating
o ??? Behavioral teratogens
o If crucial, use low dose, prn if possible
o Consider use of an antidepressant
• Antidepressants
o use lowest therapeutic dose of poorly excreted, well studied agent
o Amount in milk (largest to smallest):
Prozac>Celexa/Effexor>Zoloft/Paxil
10
Lithium in Lactation
• Relative infant dose varies from 5-20% but averages 30-40%; reports of lithium toxicity
• American Academy of Pediatrics classifies lithium as not compatible with breastfeeding
• Hale (MMM) says low dose lithium is not an absolute contraindication to breastfeeding; recommends monitoring
• Serum levels at 10 days of age (sooner if symptomatic)
• Periodic thyroid studies
• Watch for signs of dehydration
Alternative Medicine
• Most herbal preparations and vitamin supplements have not been studied with regard to their effect on the fetus and breast-fed infant.
• In many cases there is no evidence they are dangerous, but they are not known to be safe, either.
• Generally, they are best avoided in pregnant and breastfeeding women.
Commercial Herbal Teas• Generally have
accurate labeling of
the product
• Avoid teas with potent
pharmacologic
preparations
• Orange, cinnamon, lemon lift, raspberry,
and rose hips teas likely to be low risk when
used in moderate
amounts
11
Protein shakes• Nutritional shakes and powders
are ‘nutritional supplements’ and not regulated by the FDA
• May be contaminated with bacteria, pesticides, lead and other heavy metals
• Many additives (proprietary blends, herbal, weight loss) that have not been studied in pregnancy
• May result in vitamin overdose, or not eating a nutritionally complete diet
• https://mothertobaby.org/baby-blog/shake-it-up-baby-maybe-not-considering-nutritional-shakes-in-pregnancy/
Agents Potentially Contraindicated
• Known adult toxicity
oAlkanet, borage, coltsfoot, comfrey
• Stimulate GI motility
oAloe juice, cascara, Chinese
rhubarb, elecampane, purging buckthorn, senna
• Effect on thyroid
o Bladderwrack, bugleweek
Agents Potentially Contraindicated
• Sedatingo Valerian, Kava Kava
• Estrogenic effects/ may limit milk productiono Black cohosh, Chaste tree
• Not intended for use in infants or toddlerso Basil, ephedra
12
Galactogogues
• Agents intended to increase milk
volume
• Limited data to substantiate
claims
• Anecdotal reports show widely
variable results
Galactogogues• Fenugreek
o Spice used as flavor for maple syrup
o Transfer into milk is assumed; milk smells like
maple syrup
o In one study milk production doubled
o Hypoglycemic effects; potentiates warfarin
o Reports of GI bleeding, colic, abdominal upset, and diarrhea in exposed babies
13
Galactogogues
• Blessed Thistleo Antibacterial and antiinflammatory
o Low toxicity, but can cause hypersensitivity reactions and has a laxative effect
o No studies on efficacy or transfer to milk
• Fennelo Estrogenic properties
o No data on excretion or milk production, but estrogenic property may actually suppress lactation
Galactogogues• Chaste Tree
o Contains forms of progesterone and testosterone
o Used to relieve symptoms of mastodynia
o Inhibits prolactin secretion and can decrease milk production
o Generally considered contraindicated for use in nursing mothers
Vaccinations
• The CDC states that breastfeeding is not a contraindication to vaccination o Rubellao Hepatitis B
o Influenza
o Tdap
• Exception: prophylactic smallpox, Yellow fever
14
https://www.cdc.gov/breastfeeding/breastfeeding-special-
circumstances/vaccinations-
medications-
drugs/vaccinations.html?CDC_AA_refVal=https%3A%2F%2Fwww.
cdc.gov%2Fbreastfeeding%2Fre
commendations%2Fvaccinations.htm
15
16
Marijuana…legal and potent…but is it safe?
Marijuana• Marijuana contains ~400 active chemicals,
and may also contain contaminants such as
other drugs or pesticides
• Today’s marijuana up to 30x more potent than marijuana studied in the past
• Studies show pregnancy complications like
prematurity, low birth weight, and withdrawal
symptoms after birth
• Several long-term studies suggest that in-
utero marijuana can affect brain
development of the baby
• ???neuro-developmental effects of exposure through breastmilk. Most studies in the past
involved lower potency products and f/u to
only 1 year of age.
• https://mothertobaby.org/fact-
sheets/marijuana-pregnancy/
Grant KS, Conover E, Chambers CD. Update on the developmental consequences of cannabis use during
pregnancy and lactation. Birth Defects Research. 2020;1–13. https://doi.org/10.1002/bdr2.1766
Marijuana• Study Two
• 50 lactating women who
reported use of cannabis in the
previous 2 weeks provided milk samples
• In at least one sample THC was detectable 6 days after last
reported use
• Authors concluded that plasma concentrations of THC would be
several orders of magnitude
lower than maternal levels
• Study One
• 8 lactating women inhaled a
single dose of cannabis
containing 23.18% THC.
• Serial milk samples were
collected in the subsequent 4 hours
• RID 2.5% (range 0.4-8.7%)
• Infant dose not measured
directly
• Unclear as to whether there
would be accumulation of THC
in milk with chronic use
Baker, T., Datta, P., Rewers-Felkins, K., Thompson, H.,
Kallem, R. R., & Hale, T. W. (2018). Transfer of inhaled cannabisinto human breast Milk. Obstetrics and Gynecology, 131(5),
783–788. https://doi.org/10.1097/aog.0000000000002575
Bertrand, K. A., Hanan, N. J., Honerkamp-Smith, G., Best,
B. M., &Chambers, C. D. (2018). Marijuana use by breastfeeding
mothers and cannabinoid concentrations in breast Milk.
Pediatrics,
142(3), e20181076. https://doi.org/10.1542/peds.2018-
1076
17
OTC Agents “Safe” to Use in Breastfeeding Women
• Analgesics: Tylenol and ibuprofen
• Guaifenesin
• GI: Tums, Metamucil, docusate
• Multivitamins
• Topical hydrocortisone, fluconazole
• Most topical agents for acne
Likely OK in breastfeeding…..
• Claritin, Allegra
• Sparing use of
pseudoephedrine, phenylephrine
• Dextromethorphan
• Pepcid , Prilosec
• Topical pyrethrins
Usually Contraindicated in Breastfeeding
• Aspirin
• Cathartics such as
casanthral
• Sedating Agents
• Older antihistamines such
as Benadryl
• Mega doses of vitamins
• Most herbal medications
18
Cosmetic Preparations
• Topical (generally low
systemic levels and thus minimal fetal exposure)
• Poorly studied in
pregnant and breastfeeding women
• No proven risk, but in many cases limited
benefits
Tattoos
• No studies regarding safety of inks and other agents in
pregnancy or breastfeeding
• If you decide to get a tattoo, make sure it is a registered
practitioner who uses sterile
equipment and needles, sterile dressings, and sterile
packed/unopened inks
• If you feel febrile or there are other signs of infection,
contact your health provider
immediately
19
New label
New FDA Pregnancy and Lactation Labeling Rule
• Eliminates pregnancy letter catagories (ABCDX)
• Provides narrative risk
summaries on use in pregnancy and lactation
• Offers clinical
considerations
• Explains how data can
be used to determine
human risk
• Encourages updates
• All medications
approved by the FDA
since 2001 must revise their pregnancy and
lactation section
• All medications must remove ABCDX,
regardless of when approved.
Resources
• Hale, T. Medications and
Mothers’ Milk. Amarillo, TX:
Pharmasoft; 2012.
• LactMed,
http://toxnet.nlm.nih.gov/cgi-
bin/sis/htmlgen?LACT
• Briggs, G. et al. Drugs in Pregnancy and Lactation, 10th
edition. Philadelphia: Lippincott, Williams & Wilkins;
2014.
• TERIS and REPROTOX data
bases
20
FACT SHEETS
www.mothertobaby.org
• Hyperthermia
• Ciprofloxacin
• Lithium
• Influenza Vaccine
• Toxoplasmosis
• Metformin
• Zoloft
• Tegretol
• DEET
• Hair coloring
Conundrums• Pregnant women often tend to
overestimate the magnitude of teratogenic risk.
• Health providers may also have distorted perceptions of risk, even in the presence of
evidence-based facts.
• Teratogen (and other medical) data is
often limited and contradictory.
• Situations where there is no data or
inadequate data predispose to inaccurate and extreme interpretation:
o No data…assume huge risk or
o No data…assume zero risk
Facilitating Decision Making
• Use the terms ‘chance’
(likelihood, probability…)instead of
‘risk’ because them
imply less of a value judgment of good or
bad outcome
• Provide numbers in
different formats
o Ex: use both percentage
and ratio (25% or 1 in 4)
http://www/nchpeg.org
21
Non-Medication Strategies
• The combination of bright
light therapy plus an
antidepressant significantly improves
nonseasonal major depressive disorder, and
light therapy alone is
more effective than antidepressant
monotherapy, a randomized, placebo-
controlled trial suggestso JAMA Psychiatry. 2016;73(1):56-63.
Resources
• Hale, T. Medications and
Mothers’ Milk. Amarillo, TX:
Pharmasoft;
• LactMed,
http://toxnet.nlm.nih.gov/cgi-
bin/sis/htmlgen?LACT
• Briggs, G. et al. Drugs in Pregnancy and Lactation, 11th
edition. Philadelphia: Lippincott, Williams & Wilkins.
• TERIS and REPROTOX data
bases
22
New FDA Drug Label
• www.mothertobaby.org
• National Phone Number:
(866) 626-6847o option for Spanish speaking
TIS counselor
• NE-TIS
(402)-559-5071
A service of the Organization of Teratology Information Specialists
23
Case Presentations